Platelets are the major source of TGF-β in the tumor microenvironment by expression of the TGF-β-docking receptor GARP, which is highly expressed by activated Tregs (Wallace et al., 2018; Kopp et al., 2009). The gene discussed is TGFB1; the disease is neoplasm.